Chronic Hepatitis

New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release
Eberhard Hildt, Jianming Hu

Gut Apr 2024, 73 (4) 566-567; DOI: 10.1136/gutjnl-2023-331462
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
Harry L A Janssen, Jinlin Hou, Tarik Asselah, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla

Gut Jul 2023, 72 (7) 1385-1398; DOI: 10.1136/gutjnl-2022-328041
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Lütgehetmann, Haitao Guo, Stephan Urban, Simon P Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri

Gut May 2023, 72 (5) 972-983; DOI: 10.1136/gutjnl-2022-328380
Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
Elmira Aliabadi, Melanie Urbanek-Quaing, Benjamin Maasoumy, Birgit Bremer, Martin Grasshoff, Yang Li, Christian E Niehaus, Heiner Wedemeyer, Anke R M Kraft, Markus Cornberg

Gut Nov 2022, 71 (11) 2300-2312; DOI: 10.1136/gutjnl-2021-324646
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach
Mathieu Castry, Anthony Cousien, Virginie Supervie, Annie Velter, Jade Ghosn, A David Paltiel, Yazdan Yazdanpanah, Sylvie Deuffic-Burban

Gut Aug 2021, 70 (8) 1561-1569; DOI: 10.1136/gutjnl-2020-321744
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels
C Renou, P Halfon, S Pol, P Cacoub, E Jouve, J P Bronowicki, J P Arpurt, H Rifflet, M Picon, X Causse, V Canva, J Denis, A Tran, M Bourliére, D Ouzan, A Pariente, S Dantin, L Alric, V Cartier, M Reville, S Caillat-Zucman

Gut Oct 2002, 51 (4) 585-590; DOI: 10.1136/gut.51.4.585
Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases
J Miyaike, Y Iwasaki, A Takahashi, H Shimomura, H Taniguchi, N Koide, K Matsuura, T Ogura, K Tobe, T Tsuji

Gut Oct 2002, 51 (4) 591-596; DOI: 10.1136/gut.51.4.591
Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype
I Nakano, Y Fukuda, Y Katano, H Toyoda, K Hayashi, T Hayakawa, T Kumada, S Nakano

Gut Aug 2001, 49 (2) 263-267; DOI: 10.1136/gut.49.2.263
Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
P Deltenre, A Berson, P Marcellin, C Degott, M Biour, D Pessayre

Gut Jun 1999, 44 (6) 886-888; DOI: 10.1136/gut.44.6.886
Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?
Jia-Horng Kao, Thomas Berg

Gut Dec 2019, 68 (12) 2105-2106; DOI: 10.1136/gutjnl-2019-319648

Main menu

Chronic Hepatitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Chronic Hepatitis

Pages